Summary
Updated Aug 31, 2026
Scott Dunseth Myers is Director of Zentalis Pharmaceuticals, Inc. (ZNTL). 5 SEC Form 4 filings on record going back to 2024, most recently on 18 June 2026. Most recent open-market trade: bought $41K of DVAX on 25 August 2025. Lifetime open-market purchases: $41K.
Recent Transactions
6Every recent SEC Form 4 transaction Scott Dunseth Myers has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Scott Dunseth Myers go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $41K (1 buy totaling $41K). The largest single buy on record is $41K of DVAX in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Scott Dunseth Myers files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- WALTERS GROUP - $22.92M of ZNTL open-market activity in the last 12 months
- Vincent Vultaggio - $105K of ZNTL open-market activity in the last 12 months
- Julia Marie Eastland - $21K of ZNTL open-market activity in the last 12 months
- Ingmar Bruns - $8K of ZNTL open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Scott Dunseth Myers?
Scott Dunseth Myers is a corporate insider, tracked as Director of Zentalis Pharmaceuticals, Inc. (ZNTL). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Scott Dunseth Myers submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Scott Dunseth Myers been buying or selling stock?
Recorded transactions: 1 open-market purchase ($41K) and 0 open-market sales across all tracked filings.
Where can I see all of Scott Dunseth Myers's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Scott Dunseth Myers and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial